A practice facilitation-guided intervention in primary care settings to reduce cardiovascular disease risk: a cost analysis.
Cardiovascular disease prevention
Clinical guideline adherence
Cost analysis
Practice facilitation
Journal
Implementation science communications
ISSN: 2662-2211
Titre abrégé: Implement Sci Commun
Pays: England
ID NLM: 101764360
Informations de publication
Date de publication:
06 Feb 2021
06 Feb 2021
Historique:
received:
07
08
2020
accepted:
28
01
2021
entrez:
7
2
2021
pubmed:
8
2
2021
medline:
8
2
2021
Statut:
epublish
Résumé
A stepped-wedge, cluster randomized controlled trial assessed the effectiveness of practice facilitation (PF) for adoption of guidelines for prevention and treatment of cardiovascular disease risk factors. This study estimated the associated cost of PF for guideline adoption in small, private primary care practices. The cost analysis included categories for start-up costs, intervention costs, and practice staff costs for the implemented PF-guided intervention. We estimated the total 1-year costs to operate the program and calculated the mean and range of the cost-per-practice by quarter of the intervention. We estimated the lower and upper bounds for all salary expenses, rounding to the nearest $100. Total 1-year intervention costs for all 261 practices ranged from $7,900,000 to $10,200,000, with program and practice salaries comprising $6,600,000-$8,400,000 of the total. Start-up costs were a small proportion (3%) of the total 1-year costs. Excluding start-up costs, quarter 1 cost-per-practice was the most expensive at $20,400-$26,700, and quarter 4 was the least expensive at about $10,000. Practice staff time (compared with program staff time) was the majority of the staffing costs at 75-84%. The PF strategy costs approximately $10,000 per practice per quarter for program and practice costs, once implemented and running at highest efficiency. Whether this program is "worth it" to the decision-maker depends on the relative costs and effectiveness of their other options for improving cardiovascular risk reduction. This study is retrospectively registered on January 5, 2016, at www.clinicaltrials.gov as NCT02646488 .
Sections du résumé
BACKGROUND
BACKGROUND
A stepped-wedge, cluster randomized controlled trial assessed the effectiveness of practice facilitation (PF) for adoption of guidelines for prevention and treatment of cardiovascular disease risk factors. This study estimated the associated cost of PF for guideline adoption in small, private primary care practices.
METHODS
METHODS
The cost analysis included categories for start-up costs, intervention costs, and practice staff costs for the implemented PF-guided intervention. We estimated the total 1-year costs to operate the program and calculated the mean and range of the cost-per-practice by quarter of the intervention. We estimated the lower and upper bounds for all salary expenses, rounding to the nearest $100.
RESULTS
RESULTS
Total 1-year intervention costs for all 261 practices ranged from $7,900,000 to $10,200,000, with program and practice salaries comprising $6,600,000-$8,400,000 of the total. Start-up costs were a small proportion (3%) of the total 1-year costs. Excluding start-up costs, quarter 1 cost-per-practice was the most expensive at $20,400-$26,700, and quarter 4 was the least expensive at about $10,000. Practice staff time (compared with program staff time) was the majority of the staffing costs at 75-84%.
CONCLUSIONS
CONCLUSIONS
The PF strategy costs approximately $10,000 per practice per quarter for program and practice costs, once implemented and running at highest efficiency. Whether this program is "worth it" to the decision-maker depends on the relative costs and effectiveness of their other options for improving cardiovascular risk reduction.
TRIAL REGISTRATION
BACKGROUND
This study is retrospectively registered on January 5, 2016, at www.clinicaltrials.gov as NCT02646488 .
Identifiants
pubmed: 33549152
doi: 10.1186/s43058-021-00116-x
pii: 10.1186/s43058-021-00116-x
pmc: PMC7868016
doi:
Banques de données
ClinicalTrials.gov
['NCT02646488']
Types de publication
Journal Article
Langues
eng
Pagination
15Subventions
Organisme : Agency for Healthcare Research and Quality
ID : R18 HS23922-01
Références
Ann Behav Med. 2009 Apr;37(2):218-27
pubmed: 19291342
BMC Health Serv Res. 2005 Mar 09;5(1):20
pubmed: 15755330
Health Aff (Millwood). 2001 Nov-Dec;20(6):64-78
pubmed: 11816692
Ann Fam Med. 2012 Jan-Feb;10(1):63-74
pubmed: 22230833
Am J Prev Med. 2020 May;58(5):683-690
pubmed: 32067871
J Am Board Fam Med. 2018 May-Jun;31(3):398-409
pubmed: 29743223
Ann Fam Med. 2018 Apr;16(Suppl 1):S21-S28
pubmed: 29632222
Am J Med Qual. 2020 Sep 23;:1062860620959450
pubmed: 32964719
Ann Fam Med. 2013 May-Jun;11(3):207-11
pubmed: 23690319
Health Aff (Millwood). 2009 Jan-Feb;28(1):75-85
pubmed: 19124857
Front Public Health. 2017 Feb 22;5:27
pubmed: 28275594
Psychiatry Res. 2020 Jan;283:112433
pubmed: 31202612
Fam Pract. 2015 Feb;32(1):75-81
pubmed: 25281823
JAMA. 2003 Jul 9;290(2):199-206
pubmed: 12851274
Implement Sci. 2015 Oct 28;10:150
pubmed: 26510577
J Am Board Fam Med. 2012 Mar-Apr;25(2):232-7
pubmed: 22403205
Transl Behav Med. 2018 Sep 8;8(5):675-682
pubmed: 29590479
Implement Sci. 2016 Jul 04;11(1):88
pubmed: 27377404
Ann Fam Med. 2018 Apr;16(Suppl 1):S72-S79
pubmed: 29632229
Trials. 2016 Sep 05;17(1):434
pubmed: 27596224